Abbvie Inc. officer Richard A. Gonzalez is set to sell 138,616 common shares of the company, with an aggregate market value of approximately $24.57 million, on February 28, 2024. The shares to be sold were acquired on the same date as performance shares, a form of compensation from the issuer. There is no transaction history reported for Gonzalez in the past three months prior to the notice date.

Abbvie Inc. officer Richard A. Gonzalez is set to sell 138,616 common shares of the company, with an aggregate market value of approximately $24.57 million, on February 28, 2024. The shares to be sold were acquired on the same date as performance shares, a form of compensation from the issuer. There is no transaction history reported for Gonzalez in the past three months prior to the notice date.